37.54MMarket Cap-380P/E (TTM)
1.130High0.880Low158.78KVolume0.900Open0.900Pre Close158.32KTurnover4.25%Turnover RatioLossP/E (Static)34.65MShares7.79052wk High-0.50P/B4.05MFloat Cap0.52052wk Low--Dividend TTM3.74MShs Float26.602Historical High--Div YieldTTM27.77%Amplitude0.520Historical Low0.997Avg Price1Lot Size
Ocean Biomedical Stock Forum
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
Ocean Biomedical (NASDAQ:OCEA) announced a key U.S. patent issued for Dr. Jonathan Kurtis' groundbreaking malaria therapeutic antibody discovery targeting PfGARP. This patent expands protection for novel approaches to malaria prevention and treatment, including:
1. A powerful vaccine candidate for long-term pre...
Ocean Biomedical, Inc. (Nasdaq: Ocea) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
No comment yet